EY has announced the acquisition of Aqurance, a Greece-based Veeva services partner, to strengthen its capabilities in life sciences digital transformation and platform migration.

The combined entity will support clients in migrating to Veeva Vault CRM, advancing CRM innovation, regulatory transformations, and platform integrations to boost compliance and operational efficiency.

Aqurance, recognized as a Premier Services Partner for Veeva Commercial Cloud and a Services Partner for Veeva Development Cloud, brings extensive expertise in Veeva Vault and related applications, supporting clients' consulting needs.

EY Aqurance will be a platinum sponsor at the Veeva Commercial Summit in Madrid on November 5-6, 2025, showcasing its enhanced capabilities and offering clients opportunities for engagement and insights into future digital solutions.

EY’s global Life Sciences Leader, Dan Mathews, highlighted that this move will enable faster, more compliant data-driven decisions by leveraging AI and enterprise data across client operations.

He also emphasized that the acquisition allows for a more integrated strategy from planning through execution, accelerating clinical trials, improving compliance, and utilizing AI and data more effectively across the life sciences value chain.

EY’s expanded offerings aim to leverage AI and enterprise data to optimize the entire life sciences ecosystem, facilitating faster, compliant, and data-driven decision-making.